The latest updates to ICMJE’s reporting recommendations
The ICMJE recently updated its recommendations, providing guidance on issues such as use of preprint servers, conflict of interest reporting and journal metrics.
A central online news resource for professionals involved in the development of medical publications and involved in publication planning and medical writing.
The ICMJE recently updated its recommendations, providing guidance on issues such as use of preprint servers, conflict of interest reporting and journal metrics.
A free 90-minute webinar from ISMPP, open to all.
Researchers can win Wellcome Data Re-use Prizes for new insights, tools or health applications generated from re-use of open data.
A recent study published in BMC Medicine audits data sharing from pharmaceutical industry-sponsored clinical studies.
UNESCO World Science Day for Peace and Development aims to improve access and diversity in science.
The Wellcome Trust announces a new open access policy, which includes five key updates.
Tim Ellison reviews the growing importance of preprints in medical publishing.
This year’s International Open Access Week (October 22–28) is underway with a focus on designing equitable foundations for open knowledge. A host of events are scheduled across the globe, how will you get involved?
We consider if enough value is placed by academic institutions on efforts to communicate science to the public.
In a recent publication, researchers examine whether funder open access platforms are a good idea.
Robert-Jan Smits, a senior European Commission official comments on whether open access for all scientific papers by 2020 is a realistic goal.
In a recent MAP newsletter, ISMPP share an update from ASCO on their new open access option for industry-funded research.
Mary Yianni, Publisher at Taylor and Francis, reviews the different models of peer review and the emerging role of preprints.
Don’t forget! From 1 July 2018, ICMJE requires all reports of clinical trial data to include a data sharing statement.
Missed the 14th Annual Meeting of ISMPP? Read the second part of our meeting report to get up to speed!
A new study from the AllTrials team sheds light on clinical trial reporting rates by non-industry sponsors.